Lucid Diagnostics (LUCD) Capital Expenditures (2021 - 2026)

Lucid Diagnostics' Capital Expenditures history runs 5 years deep, the most recent figure standing at $215000.0 for Q1 2026.

• Quarterly Capital Expenditures rose 131.18% year-over-year to $215000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $325000.0 (down 70.72% YoY) and the FY2025 annual result came in at $197000.0, down 33.45% from the prior year.
• Capital Expenditures was $215000.0 for Q1 2026 at Lucid Diagnostics, up from $93000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $2.1 million in Q2 2022 and bottomed at $17000.0 in Q1 2023.
• A 4-year average of $587500.0 and a median of $181500.0 in 2022 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2022 — Capital Expenditures jumped 205100.0% — and 2023, when it sank 88.51%.
• Lucid Diagnostics' Capital Expenditures stood at $1.0 million in 2022, then tumbled by 98.3% to $17000.0 in 2023, then soared by 447.06% to $93000.0 in 2025, then soared by 131.18% to $215000.0 in 2026.
• Business Quant data shows LUCD's Capital Expenditures at $215000.0 in Q1 2026, $93000.0 in Q1 2025, and $17000.0 in Q1 2023.